The 1st International Online Conference on Personalized Medicine
Part of the International Online Conference on Personalized Medicine series
The IOCPM2025 Conference has Closed!
The Best Oral Presentation Awards and Best Poster Awards of IOCPM 2025 will be announced soon.
You can directly download your electronic Certificate of Attendance HERE.
Click HERE for the abstract book.
Click HERE for the poster gallery.
Accepted abstracts are eligible for publication in a Special Issue of Journal of Personalized Medicine ( ISSN: 2075-4426), with a 20% discount on the publication fee.
Click HERE for more details.
the chair
S2. Personalized Preventive Medicine;
S3. Diagnostics in Personalized Medicine;
S4. Personalized Therapy in Clinical Medicine;
S5. Pharmacogenetics, Omics, and Informatics;
S6. Precision Oncology.
IOCPM 2025 will enable you to share and discuss your most recent research findings in Personalized Medicine with the vibrant global community of scientists and physicians in the field.
Prof. Dr. Kenneth P. H. Pritzker
MD, FRCPC
Professor Emeritus,
Laboratory Medicine and Pathobiology;
Surgery Temerty Faculty of Medicine,
University of Toronto, Toronto, Canada
Conference Chair of the 1st International Online Conference on Personalized Medicine
Meet the Event Chair
Important Dates
- Abstract submission deadlineAug 11, 2025
- Abstract acceptance notificationSep 12, 2025
- Registration end dateOct 24, 2025
Meet Our Speakers
Prof. Enrico Mini
Emeritus Professor of Medical Oncology, Department of Health Sciences, University of Florence, Florence, Italy;
Prof. Mini is an Emeritus Professor of Medical Oncology at the Department of Health Sciences, University of Florence (Italy). His research interests comprise the mechanisms of tumor drug resistance, in particular to antimetabolites and metal-based drugs, cancer pharmacogenomics and pharmacogenetics, and controlled clinical trials in gastrointestinal cancers. His studies have contributed to the advancement of knowledge in the field of biochemical bases of anticancer drug synergism and molecular bases of anticancer drug resistance. Prof. Mini is the author of more than 190 original articles in international peer reviewed journals and about 80 reviews, editorials, book chapters, and letters. He has given over 260 invited talks at national and international conferences and seminars at Italian and foreign universities and has presented more than 350 communications at scientific congresses. In recognition of his outstanding achievements, Prof. Mini has received various awards and recognitions and grants for his research results, including the Leukemia Society of America Special Fellow Award in 1982, the Lady Tata Memorial Trust Award, the Alberico Benedicenti Italian Society of Pharmacology Special Mention Award in 1988 and in 2019 the 'International Society of Antimicrobial Chemotherapy (ISAC) Fellow Award (London). Prof. Mini has also held prestigious positions in various scientific societies. He is currently the Coordinator of the Cancer Pharmacology Working Group of the Italian Society of Pharmacology
Prof. Dr. Yves. A. Lussier
Department of Biomedical Informatics and Center for Genomic Medicine, University of Utah Eccles School of Medicine, Salt Lake City, USA;
Prof. Dr. Yves A. Lussier, MD, FAMIA, FACMI is Chair of Biomedical Informatics at the University of Utah School of Medicine. A professional engineer and physician-scientist, he is recognized internationally as a pioneer in translational bioinformatics, systems biology, and high-throughput approaches in personalized medicine.
Previously, Prof. Dr. Lussier held leadership roles at the University of Arizona, where he directed the Center for Biomedical Informatics and Biostatistics, and at the University of Illinois and University of Chicago, advancing biomedical informatics, computational genomics, and precision health initiatives. His career began at Columbia University, where he was Assistant Professor of Biomedical Informatics and Medicine.
With over 185 publications, 100 invited talks (including 28 international keynotes), and more than $190M in research funding, Prof. Dr. Lussier has made lasting contributions to data science–driven precision medicine. He has mentored over 90 trainees, many of whom have gone on to secure major awards and faculty positions. His honors include three IBM Faculty Awards, Fellowship in the American College of Medical Informatics, and an invitation to the White House Precision Medicine Summit.
Prof. Dr. Weikuan Gu
Department of Orthopaedic Surgery, University of Tennessee Health Science Center, USA;
Dr. Weikuan Gu, PhD, obtained his PhD from Cornell University. He is tenured and a full Professor in the Department of Orthopaedic Surgery and Biomedical Engineering. He is the Director of translational research in the department and the director of the DNA Discovery Core of the UTHSC Center of Genomics and Bioinformatics. Dr. Gu has a joint appointment in the Department of Pharmaceutics Sciences in the College of Pharmacy. He has published more than 140 peer reviewed full publications, more than 100 abstracts/ presentations/invited lectures, and 10 book chapters. He edited a book named “Gene Discovery for Disease Models”, which was published in early 2011. He also holds a patent for the identification of suitable patients for orally induced tolerance to arthritis and scleroderma. He served as a member of the editorial board for the Case report (during 2008 and 2010), Chinese Journal of Endemiology, Annals of Musculoskeletal Disorders, and the Journal of Personalized Medicine. He serves as a reviewer for 21 medical science journals. He has coordinated many collaborative international education and research activities. He has trained and/or coordinated the training of more than 100 people, including post-doctoral researchers, graduate students, summer students, and visiting scientists.
Dr. Latha Palaniappan
Stanford Concierge and Executive Medicine, Stanford University, California, USA;
Latha Palaniappan MD, MS, is an internist, and clinical and population researcher. Her research has focused on the study of diverse populations, chronic disease and prevention, and seeks to address the gap in knowledge of health in Asian subgroups and other understudied racial/ethnic minorities. She was awarded a Stanford Impact Labs Leave in Service to pursue chronic disease prevention in India for Social Good. She is the Faculty co-Director of Stanford Biobank, designed to accelerate translatable scientific discoveries and co-founder for the Stanford Center for Asian American, Native Hawaiian and Pacific Islander Health Research and Education (CARE). CARE has established health related research collaborations in Asia, including student exchange programs in Hong Kong and Vietnam, and research collaborations in India, Japan, and Singapore. She has recently received a Fulbright Future Scholar Award and worked with the Commonwealth Scientific and Industrial Research Organization on implementation of Precision Health in Australia.
Dr. Davide Barbagallo
Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy;
Dr Davide Barbagallo (DB) held a PhD in Biology, human genetics and bioinformatics in 2009 (supervisor: Prof. Michele Purrello), both from the University of Catania, Italy. From 2009 to 2019 DB carried on his research activity as PostDoc at University fo Catania, under the supervision of Prof. Michele Purrello. and Prof. Cinzia Di Pietro. In 2017 DB held specialization in medical genetics at University of Messina by discussing a thesis on the involvement of circular RNAs (circRNAs) in the pathogenesis of glioblastoma multiforme (GBM). His early studies were focused on the involvement of a set of transcripts belonging to the apoptotic machinery and to the class of microRNAs (miRNAs) in the etiology of diabetes mellitus. Since 2016, his scientific interests shifted towards the study of brain cancer, focusing on the involvement of miRNAs and circRNAs in its pathogenesis. DB collaborated to research activities on the involvement of non-coding RNAs in the field of human infertility and cancer. In 2017, thanks to the win of a travel grant sponsored by Umberto Veronesi Foundation, DB moved to Aarhus University (Denmark) where he learnt the main techniques to study the function of circRNAs and applied this knowledge to the study of functional involvement of circSMARCA5 in the pathogenesis of GBM, under the guidance of Dr. Thomas Hansen. DB has authored or co-authored more than 40 peer-reviewed scientific publications on impacted international journals, up today. Since 2020 DB is Assistant Professor of Applied Biology (SSD BIO/13) at University of Catania. Since 2023 DB is Associate Professor of Applied Biology (SSD BIO/13) at University of Catania.
Dr. Masakazu Kamata
Department of Microbiology, Heersink School of Medicine, University of Alabama, Birmingham, AL, USA;
Our research team is focused on creating a clinically relevant animal model to enhance our understanding of biology and develop new therapies for metastatic cancer and HIV-infected cells. Each model aims to investigate the complex mechanisms of cancer or HIV biology and their treatment effects at the molecular scale. Uncovering specific pathways has led to the emergence of new pharmaceuticals, such as antibody-drug conjugates, immunomodulators, and chimeric antigen receptors.
Dr. Taulant Muka
Epistudia, Bern, Switzerland;
Dr. Taulant Muka is among the top 2% of the world’s most influential scientists, with over 180 peer-reviewed publications and extensive expertise in evidence-based medicine and public health. As CEO of Epistudia, he pioneers education innovation through AI and e-learning tools. Dr. Muka's academic journey spans prestigious institutions like University of Bern, Erasmus, Cambridge, Harvard, and Stanford, with research focusing on cardiometabolic health, sex differences, and evidence synthesis. His work has been featured in global media outlets like BBC, CNN, and The New York Times.
Prof. Dr. Kenneth P.H. Pritzker
Laboratory Medicine and Pathobiology; Surgery, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada;
Dr. Pritzker is Professor Emeritus in the Department of Laboratory Medicine and Pathobiology; Department of Surgery, Temerty Faculty of Medicine, and the Institute of Biomedical Engineering, University of Toronto and is Honorary Staff , Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto. Dr. Pritzker served as Chief, Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto from 1986 to 2008. With over 290 scientific publications and 27 book chapters, Ken is a recognized leader internationally in the fields of arthritis, biomaterials, genomics, cancer diagnostics and nanotechnology. Dr. Pritzker served on the External Advisory Board, Institute of Microstructural Sciences, National Research Council of Canada, 2005-2011. Dr. Pritzker serves as editor-in-chief, Journal of Personalized Medicine.
- S1. Mechanisms of Diseases
- S2. Personalized Preventive Medicine
- S3. Diagnostics in Personalized Medicine
- S4. Personalized Therapy in Clinical Medicine
- S5. Pharmacogenetics, Omics, and Informatics
Sponsors and Partners
Organizer
Media partner
|
ID |
Title |
Authors |
| sciforum-144137 | Precision Proteomics for Personalized Medicine: A Unified MS1/MS2 Linear Mixed-Effects Model for Robust Biomarker Identification |
Vy Ong, Kaitlin Lowran, Anna Lokshin, Paul Stemmer, Seongho Kim |
| sciforum-134107 | Investigating the Role of CD151 in Systemic Breast Cancer Metastasis | Kevin Liu, Naoki Hama, Charles Kuhlmann, Chloe Jepson, Madison Blucas, Yoshiko Nagoka-Kamata, Masakazu Kamata |
| sciforum-140061 | High-risk genetic profiles for Pharmacoresistant Schizophrenia: Insights from Belarusian Patients | Irina Haidukevich, Tatsiana Golubeva, Inna Halayenka, Victor Obedkov, Olga Bokut, Gennady Sergev, Tatsiana Dakukina |
| sciforum-125147 | Evaluation of the Choroidal Thickness and Retinal Nerve Fiber Layer Thickness in Patients with Vasovagal Syncope | Batur Gonenc Kanar, Hasan Burak Isleyen, Hatice Selen Kanar, Mehmet Vefik Yazicioglu, Guzide Akcau |
IOCPM 2025
DAY 1
Session 5. Pharmacogenetics, Omics, and Informatics
Session 1. Mechanisms of Diseases